Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 08:45 (747 d 08:29 ago) – Posting: # 20125
Views: 2,669

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 13 (0 registered, 13 guests [including 5 identified bots]).
Forum time: Wednesday 17:14 CEST (Europe/Vienna)

In the Middles Ages the lingua franca of science was Latin.
Nowadays the language of science is bad English.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5